Cancer Research in Switzerland - Krebsliga Schweiz

New organization of the Foundation Cancer Research Switzerland and Oncosuisse
In the fall of 2009 the course was determined for a new strategic and operational direction
of the Foundation Cancer Research Switzerland (CRS) and Oncosuisse. The goal of the new
organization was to simplify the structures and processes of research funding and to focus
on the core competencies of the two organizations. Previously, Oncosuisse had been responsible
for awarding the monies generated by the CRS to the researchers. Under the new
organization, the CRS foundation board is responsible for this task. To this purpose, a new
board was formed and expanded: The board now has one representative each from the
Swiss Cancer League (SCL), the Swiss Group for Clinical Cancer Research (SAKK), and
the Swiss Paediatric Oncology Group (SPOG), one expert in each of the different research
areas, a financial specialist, and further independent persons.
Within the framework of the new organization, Oncosuisse, the Swiss Federation Against
Cancer founded in 1999, became a simple association. As a platform it focuses on coordinating
and representing the strategic policies of the Swiss network working against cancer.
Its most important task is developing and implementing the National Cancer Programme
2011–2015 (NCP II). This policy instrument aims to coordinate at the national level and improve
cancer research, prevention, early detection, cancer treatment, and coping with the
effects of the disease. Since 2011, the NCP II functions as the national guide in the fight
against cancer. Oncosuisse is financed by the membership fees of its five partners: CRS, SCL,
SAKK, SPOG, and the National Institute for Cancer Epidemiology and Registration (NICER).
Contact information
Oncosuisse
Effingerstrasse 40
CH-3008 Bern
Phone +41 (0)31 389 93 00
Fax +41 (0)31 389 92 00
info@oncosuisse.ch
www.oncosuisse.ch
17